KRTAP4-4: A Potential Drug Target and Biomarker (G84616)

Target Name: KRTAP4-4

NCBI ID: G84616

KRTAP4-4

KRTAP4-4: A Potential Drug Target and Biomarker

KRTAP4-4 (KRTAP4.4) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the KRTAS family, which includes known proteins that are involved in the regulation of RNA splicing. The KRTAS family is known to play a role in the development and maintenance of various diseases, including neurodegenerative disorders and chronic kidney disease.

Recent studies have identified KRTAP4-4 as a potential drug target and biomarker for a variety of diseases. In addition to its potential clinical applications, KRTAP4-4 also has implications for basic research into the regulation of RNA splicing and its role in disease.

The Potential Role of KRTAP4-4 as a Drug Target

KRTAP4-4 has been shown to play a role in the regulation of RNA splicing, which is the process by which the cell removes non-coding regions from the RNA molecule and adds coding regions. This process is important for the production of functional RNA molecules that are involved in various cellular processes.

Studies have shown that KRTAP4-4 is involved in the regulation of RNA splicing in a variety of tissues and cells. For example, researchers have found that KRTAP4-4 is expressed in the brain and that it is involved in the regulation of gene expression in this tissue. Additionally, studies have shown that KRTAP4-4 is involved in the regulation of RNA splicing in the kidneys, which are responsible for removing waste products from the blood.

These findings suggest that KRTAP4-4 may be a potential drug target for a variety of diseases. By targeting the regulation of RNA splicing, KRTAP4-4 may be able to modulate the expression of genes involved in the development and progression of these diseases.

The Potential Role of KRTAP4-4 as a Biomarker

In addition to its potential role as a drug target, KRTAP4-4 has also been shown to be a potential biomarker for a variety of diseases. Studies have shown that KRTAP4-4 is expressed in a variety of tissues and cells, including the brain, heart, and kidneys. This suggests that KRTAP4-4 may be a useful biomarker for the diagnosis and monitoring of various diseases.

For example, KRTAP4-4 has been shown to be involved in the regulation of gene expression in the brain, which may be useful for the diagnosis and treatment of neurodegenerative disorders. Additionally, KRTAP4-4 has been shown to be involved in the regulation of gene expression in the kidneys, which may be useful for the diagnosis and treatment of chronic kidney disease.

These findings suggest that KRTAP4-4 may be a useful biomarker for the diagnosis and monitoring of a variety of diseases. By studying the regulation of gene expression in different tissues and cells, researchers may be able to identify new biomarkers and therapeutic targets for a variety of diseases.

Conclusion

KRTAP4-4 is a protein that is expressed in various tissues of the body and has been shown to play a role in the regulation of RNA splicing. In addition to its potential clinical applications, KRTAP4-4 has also been shown to be a potential drug target and biomarker for a variety of diseases. Further research is needed to fully understand the regulation of RNA splicing by KRTAP4-4 and its potential as a drug target and biomarker.

Protein Name: Keratin Associated Protein 4-4

Functions: In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins

The "KRTAP4-4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRTAP4-4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets